Who should be tested Initial screening Subsequent evaluations
Read MoreA review of published data regarding the use of aromatase inhibitors in pediatrics.
Read MoreMembers of the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society describe the changes in the prescribing information for the different forms of
rhGH.
A Scientific Statement from the American Heart Association on Drug Therapy of High-Risk Lipid Abnormalities in Children and Adolescents.
Read MoreThe birth of an intersex child prompts a long-term management strategy that involves myriad professionals working with the family. There has been progress in diagnosis, surgical…
Read More